Citation Impact
Citing Papers
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
A type I interferon autocrine–paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells
2005
Iduronic Acid-Containing Glycosaminoglycans on Target Cells Are Required for Efficient Respiratory Syncytial Virus Infection
2000
Heparin-Like Structures on Respiratory Syncytial Virus Are Involved in Its Infectivity In Vitro
1998
Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways
2012
Human Cytotoxic T Lymphocyte Responses to Live Attenuated 17D Yellow Fever Vaccine: Identification of HLA-B35-Restricted CTL Epitopes on Nonstructural Proteins NS1, NS2b, NS3, and the Structural Protein E
2002
Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1
1994
Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection
2018
Manipulation of cell surface macromolecules by flaviviruses
2003
Toll receptors and pathogen resistance
2003
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice
1991
Regulation of the type I IFN induction: a current view
2005
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
2013 StandoutNobel
Genetic analysis of resistance to viral infection
2007 StandoutNobel
Respiratory Syncytial Virus Pneumonia among the Elderly: An Assessment of Disease Burden
1999
Dual Detection of Fungal Infections in Drosophila via Recognition of Glucans and Sensing of Virulence Factors
2006 StandoutNobel
Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells
1989
Cell Type-Specific Involvement of RIG-I in Antiviral Response
2005
Progressive epitope-blocked panning of a phage library for isolation of human RSV antibodies
2002
Saturated Fatty Acid Activates but Polyunsaturated Fatty Acid Inhibits Toll-like Receptor 2 Dimerized with Toll-like Receptor 6 or 1
2004 Standout
Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in Infancy
2000
Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response
2003
Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study
2001
Does Toll-like receptor 3 play a biological role in virus infections?
2004
IRF3 Mediates a TLR3/TLR4-Specific Antiviral Gene Program
2002
Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes
2004
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
2020 Standout
Reduction of Yellow Fever Virus Mouse Neurovirulence by Immunization with a Bacterially Synthesized Non-structural Protein (NS1) Fragment
1988
Respiratory Syncytial Virus Is an Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized Adults
1996
Toll-like receptor signalling
2004 Standout
Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990
1996
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Acute Respiratory Tract Infection in Daycare Centers for Older Persons
1995
Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread
2017 StandoutNobel
The immune response of Drosophila
2003 StandoutNatureNobel
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996
1999
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis
2004
Incubation periods of acute respiratory viral infections: a systematic review
2009
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Toll-like receptors and innate antiviral responses
2003
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
2003 StandoutNatureNobel
Toll-like receptors: critical proteins linking innate and acquired immunity
2001 Standout
Winter Viruses
2002
Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells
2004 StandoutNobel
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Single amino-acid changes in HIV envelope affect viral tropism and receptor binding
1989 StandoutNatureNobel
Influenza
2018 Nobel
Improved Diagnosis of the Etiology of Community-Acquired Pneumonia with Real-Time Polymerase Chain Reaction
2005
Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer
1988
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy
1993 StandoutNatureNobel
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Pathogen Recognition and Innate Immunity
2006 Standout
Protective Efficacy of Combined Live Intranasal and Inactivated Influenza A Virus Vaccines in the Elderly
1992
Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells
1992 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein
2001 StandoutNatureNobel
Toll-like receptors and innate immunity
2001 Standout
Respiratory Syncytial and Other Virus Infections in Persons with Chronic Cardiopulmonary Disease
1999
Toll-Like Receptors
2003 Standout
Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.
1987 StandoutNobel
Flavivirus Replication Strategy
1987
Recognition of single-stranded RNA viruses by Toll-like receptor 7
2004
Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a
1989
The Soluble Form of Human Respiratory Syncytial Virus Attachment Protein Differs from the Membrane-Bound Form in Its Oligomeric State but Is Still Capable of Binding to Cell Surface Proteoglycans
2004
Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype
1986
Viral evasion and subversion of pattern-recognition receptor signalling
2008
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Cloning full-length dengue type 4 viral DNA sequences: Analysis of genes coding for structural proteins
1986
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact
2016
High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model
1992
TLR-Independent Induction of Dendritic Cell Maturation and Adaptive Immunity by Negative-Strand RNA Viruses
2004
Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis
1990
Recombinant Respiratory Syncytial Virus That Does Not Express the NS1 or M2-2 Protein Is Highly Attenuated and Immunogenic in Chimpanzees
2000
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
1996 StandoutNobel
Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturation
2008 StandoutNobel
Yellow fever vaccine
2005
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection
2003
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression
2005
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization
1989
TLRs and innate immunity
2008 StandoutNobel
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus
2006 StandoutNobel
Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation
1997 StandoutNobel
Partial nucleotide sequence of the Murray Valley encephalitis virus genome
1986 StandoutNobel
Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis
1988
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
2019
Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen
2002
Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin
2001
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
2004 StandoutNobel
Immunization with nonstructural proteins promotes functional recovery of alphavirus-infected neurons
1997 StandoutNobel
Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1
1986
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large
2006 StandoutNobel
Innate Immune Recognition
2002 Standout
Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1
1987 Science
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
2003
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
2006 StandoutScienceNobel
Aerosol gene delivery in vivo.
1992
Structure and organization of the hepatitis C virus genome isolated from human carriers
1991
Plant and Animal Sensors of Conserved Microbial Signatures
2010 StandoutScienceNobel
The Fusion Glycoprotein of Human Respiratory Syncytial Virus Facilitates Virus Attachment and Infectivity via an Interaction with Cellular Heparan Sulfate
2000
Pathogenesis of Dengue: Challenges to Molecular Biology
1988 StandoutScience
Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein.
1990 StandoutNobel
Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses
1986 StandoutNobel
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of Edward E. Walsh being referenced
Transcriptomic Biomarkers to Discriminate Bacterial from Nonbacterial Infection in Adults Hospitalized with Respiratory Illness
2017
Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres
2009
Respiratory syncytial virus infection in the elderly
1996
Severity of Respiratory Syncytial Virus Infection Is Related to Virus Strain
1997
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
2005 Standout
Humoral immunity to respiratory syncytial virus infection in the elderly
1992
Rhinovirus and Coronavirus Infection–Associated Hospitalizations among Older Adults
2002
Serologic Evidence of Respiratory Syncytial Virus Infection in Nursing Home Patients
1990
Relationship of Serum Antibody to Risk of Respiratory Syncytial Virus Infection in Elderly Adults
1998
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly
1997
Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody
1990
Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations
2013
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60
1996
Human Metapneumovirus Infections in Young and Elderly Adults
2003
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures
2015
Clinical Features of Influenza A Virus Infection in Older Hospitalized Persons
2002
Immunogenicity of a Purified Fragment of 170 Yellow Fever Envelope Protein
1990
Immunogenicity of Purified F Glycoprotein of Respiratory Syncytial Virus: Clinical and Immune Responses to Subsequent Natural Infection in Children
1993
Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults
2003
Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults
1999
Immunity to and Frequency of Reinfection with Respiratory Syncytial Virus
1991
Viral Respiratory Infections in the Institutionalized Elderly: Clinical and Epidemiologic Findings
1992
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
2000
Purification and Characterization of GP90, One of the Envelope Glycoproteins of Respiratory Syncytial Virus
1984
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
1986
Analysis of 17D Yellow Fever Virus Envelope Protein Epitopes Using Monoclonal Antibodies
1984
Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
1985
Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein
1983
Immunization with Glycoprotein Subunits of Respiratory Syncytial Virus to Protect Cotton Rats Against Viral Infection
1987
Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral Infection
1983
Protection of Mice Against Dengue 2 Virus Encephalitis by Immunization with the Dengue 2 Virus Non-structural Glycoprotein NS1
1987
Variation in severity of respiratory syncytial virus infections with subtype
1990
Respiratory Syncytial Virus Infection in Adults
2000
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity
1987
Lethal 17D Yellow Fever Encephalitis in Mice. I. Passive Protection by Monoclonal Antibodies to the Envelope Proteins of 17D Yellow Fever and Dengue 2 Viruses
1986
Respiratory Syncytial Virus Grown in Vero Cells Contains a Truncated Attachment Protein That Alters Its Infectivity and Dependence on Glycosaminoglycans
2009
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection
1986
Respiratory Syncytial Virus Infection in Adults
2000